VÉSALE BIOSCIENCE

Press

L’Écho

Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT

La Libre

Vésale Bioscience enters into an innovative and ambitious collaboration with the Belgian Army

Lpost

Important reinforcement for Vésale Bioscience: the managers of Vésale Bioscience have hired Guillaume de Viron as Chief Financial Officer (CFO) of the research and development (R&D) company

L’Écho

Vésale Bioscience raises a first tranche of €3 million: in preparation for its IPO, which has been brought forward to the end of 2022, Vésale Bioscience has raised a first tranche of funds from private investors.